Search
HOOKIPA Pharma Inc
HOOKAdd to Watchlist
0.840USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
10.14MMarket Cap
LossP/E TTM
More Details of HOOKIPA Pharma Inc Company
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
HOOKIPA Pharma Inc Info
Ticker SymbolHOOK
Company nameHOOKIPA Pharma Inc
IPO dateApr 18, 2019
CEODr. Malte Peters, M.D.
Number of employees82
Security typeOrdinary Share
Fiscal year-endApr 18
Address350 Fifth Avenue, 72Nd Floor, Suite 7240
CityNEW YORK
Stock exchangeUS 'Other OTC' and Grey Market
CountryUnited States of America
Postal code10118
Phone114318906360
Websitehttps://www.hookipapharma.com/
Ticker SymbolHOOK
IPO dateApr 18, 2019
CEODr. Malte Peters, M.D.
Company Executives of HOOKIPA Pharma Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Julie O'Neill
Ms. Julie O'Neill
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
496.00
-0.04%
Mr. Sean A. Cassidy
Mr. Sean A. Cassidy
Independent Director
Independent Director
--
--
Dr. Malte Peters, M.D.
Dr. Malte Peters, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
-100.00%
Dr. David R. Kaufman, M.D., Ph.D.
Dr. David R. Kaufman, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Terry Coelho
Ms. Terry Coelho
Chief Financial Officer, Executive Vice President, Director
Chief Financial Officer, Executive Vice President, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Julie O'Neill
Ms. Julie O'Neill
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
496.00
-0.04%
Mr. Sean A. Cassidy
Mr. Sean A. Cassidy
Independent Director
Independent Director
--
--
Dr. Malte Peters, M.D.
Dr. Malte Peters, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
-100.00%
Dr. David R. Kaufman, M.D., Ph.D.
Dr. David R. Kaufman, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Terry Coelho
Ms. Terry Coelho
Chief Financial Officer, Executive Vice President, Director
Chief Financial Officer, Executive Vice President, Director
--
--
FAQs
Who are the top five shareholders of HOOKIPA Pharma Inc?
The top five shareholders of HOOKIPA Pharma Inc are: Ms. Julie O'Neill
How many institutions hold shares of HOOKIPA Pharma Inc (HOOK)?
As of 2026Q1, 73 institutions hold shares of HOOKIPA Pharma Inc, with a combined market value of approximately 327.48K, accounting for 3.30% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3304608.00.